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Background: Lymphocyte migration and chemotaxis are essential for effective immune surveillance. A critical
aspect of migration is cell polarization and the extension of pseudopodia in the direction of movement. However,
our knowledge of the underlying molecular mechanisms responsible for these events is incomplete. Proteomic
analysis of the isolated leading edges of CXCL12 stimulated human T cell lines was used to identify glia maturation
factor gamma (GMFG) as a component of the pseudopodia. This protein is predominantly expressed in
hematopoietic cells and it has been shown to regulate cytoskeletal branching. The present studies were undertaken
to examine the role of GMFG in lymphocyte migration.
Results: Microscopic analysis of migrating T-cells demonstrated that GMFG was distributed along the axis of
movement with enrichment in the leading edge and behind the nucleus of these cells. Inhibition of GMFG
expression in T cell lines and IL-2 dependent human peripheral blood T cells with shRNAmir reduced cellular basal
and chemokine induced migration responses. The failure of the cells with reduced GMFG to migrate was associated
with an apparent inability to detach from the substrates that they were moving on. It was also noted that these
cells had an increased adherence to extracellular matrix proteins such as fibronectin. These changes in adherence
were associated with altered patterns of β1 integrin expression and increased levels of activated integrins as
detected with the activation specific antibody HUTS4. GMFG loss was also shown to increase the expression of the
β2 integrin LFA-1 and to increase the adhesion of these cells to ICAM-1.
Conclusions: The present studies demonstrate that GMFG is a component of human T cell pseudopodia required
for migration. The reduction in migration and increased adherence properties associated with inhibition of GMFG
expression suggest that GMFG activity influences the regulation of integrin mediated adhesion.
Keywords: T lymphocytes, Chemotaxis, CXCL12, Pseudopodia, Glia maturation factor gamma, GMFG, Proteomics,
ShRNAmir, AdhesionBackground
T Lymphocytes are involved in various aspects of immune
functions such as surveillance, inflammation and wound
healing. These activities are dependent upon the chemo-
taxis of immune cells to sites of antigen deposition or
inflammation [1,2]. Lymphocyte chemotaxis involves an
iterative series of coordinated molecular events including* Correspondence: jwilkin@cc.umanitoba.ca
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distribution, and reproduction in any mediumcell polarization, adhesion and force generation [3,4]. The
molecular processes required for cell movement and
recruitment are not fully understood. This derives in part
from an incomplete knowledge of the cellular components
that are required for chemotaxis. We performed a detailed
mass spectrometry based compositional analysis of the
isolated pseudopodia of migrating T lymphocytes as an
approach to understanding the molecular basis for these
processes. One of the components identified in pseudopo-
dia was Glia maturation factor γ (GMFG) suggesting that
it might play a role in the migration or chemotaxis of T
lymphocytes. While the current studies were in progress itentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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of human neutrophils [5].
GMFG is a 17 kDa protein which, contrary to the
name, is not involved in the development of glia or the
formation of gliomas [6]. Rather it is highly expressed in
the thymus, spleen, lung and in highly motile cell types
such as lymphoblasts, T-lymphocytes, macrophages and
fibroblasts [7,8]. GMFG has a high level of structural
similarity with members of the ADF (actin depolymer-
isation factor) domain containing family suggesting that
it might play a role in the remodeling of the actin cyto-
skeleton [8]. Although an early study suggested that
GMFG directly interacted with actin filaments [7], subse-
quent reports using purified actin and a GMFG homolog
from yeast have yielded conflicting results [9,10]. Several
groups have shown that GMFG and its homologs interact
with purified Arp2/3 complex [7,9,10] and interfere with
Arp2/3 induced daughter filament growth. They also
cause removal of actin branches from the parent actin fila-
ment (i.e. pruning). These observations suggested that
GMFG may be involved in cell movement, possibly by de-
fining the location of Arp2/3 dependent actin branching
required for membrane extension or by providing a mech-
anism for the regeneration of the actin monomer pool
required for continued cell pseudopodia extension.
The present study demonstrates that GMFG is
required for the migration and chemotaxis of human
T-lymphocytes. The loss of GMFG results in reduced
cell migration which appears to be associated with
altered integrin expression and increased cell adhesion.
These results suggest that GMFG may be required for
the proper control of cellular adhesion which is essen-
tial for cell movement.
Results
GMFG is present in the pseudopodia of SDF1 treated
T-lymphocytes
The intent of our studies was to examine the roles of
proteins found in the pseudopodia of chemotactically
stimulated lymphocytes. Pseudopodia of SDF1 stimu-
lated Jurkat cells were isolated from the undersides of
transwell insert membranes containing 3 μm pores. The
pores prevented full transmigration but did permit
pseudopodia extensions through the membrane pores.
The proteins in the pseudopodia were subsequently
identified by mass spectrometry.
Glia maturation factor gamma was consistently identi-
fied by mass spectrometry in all of the pseudopodia iso-
lates from SDF1 stimulated Jurkat. The peptides that
were identified for GMFG are listed in Additional file 1.
However, GMFG was not detected when the same
amount of protein from whole cell lysates was examined
by mass spectrometry under identical conditions. Clearly
GMFG must be present in the lysates of cells that thepseudopodia were isolated from. However, the presence
of GMFG was potentially masked by the presence of
higher abundance proteins that were reduced in the
pseudopodia preparations. A western blot based com-
parison of GMFG levels in pseudopodia and cell lysates,
confirmed that GMFG was enriched ~1.5-fold in
pseudopodia relative to whole cell lysates (Figure 1A&B).
Immunofluorescence microscopy further demonstrated
that GMFG was recruited to the leading edge of SDF1
stimulated IL-2 dependent peripheral blood T-lympho-
cytes (arrowheads, Figure 1C&E). However, GMFG was
also detected throughout the cell body particularly in
the region immediately behind the nuclei of migrating
cells. Similar distributions were also observed in migrat-
ing Jurkat and CCRF-CEM cells (not shown). These
results indicated that a component of the total cellular
GMFG pool was recruited to the leading edges of mi-
grating T cells and enriched relative to the cell bodies.
GMFG is required for SDF1 induced T-lymphocyte
chemotaxis
The accumulation of GMFG in the leading edge of the
cell suggested that it could be involved in cell migration.
The role of GMFG in these processes was examined
using shRNA to reduce GMFG protein expression levels.
Jurkat cells were transduced with one of three distinct
shRNA clones that targeted different regions of the
GMFG sequence. Western blot analysis of GMFG levels
demonstrated that each of these clones caused a 65–76%
reduction in GMFG levels relative to cells transduced
with a non-silencing control vector (Figure 2A). The
control transductants had GMFG levels similar to those
of wild type Jurkat cells suggesting that the transduction
process per se did not impact on the expression of this
protein.
Reduction of GMFG expression levels did not impact
on cellular architecture or proliferation suggesting that it
was not essential for these processes. However, the SDF1
induced chemotaxis of cells with reduced GMFG was
inhibited by 69–95% compared with either non-silencing
control transductants or untransduced Jurkat cells
(Figure 2B).
The loss of chemotaxis could arise from changes in
cellular motility or a failure of cells to respond to che-
mokine stimulation. The effects of GMFG knockdown
(GMFG-KD) on migration rates were examined in IL-2
dependent T cells. Cell tracking plots clearly demon-
strated the reduced motility of GMFG-KD cells in com-
parison to non-silencing controls (Figure 3A). A closer
inspection of the knockdown cells showed that they were
able to polarize and extend pseudopodia. However, the
knockdown cells were unable to fully detach from their
initial positions and the observed pseudopodia were
rapidly collapsed and formed at one or more new sites
Figure 2 Effects of shRNA mediated reduction of GMFG
expression on T cell migration. A) The efficiency of GMFG
knockdown in Jurkat cells was assessed by western blot. Lanes 1–3
contained lysates from lines generated with three different shRNA
targeting GMFG. Lanes NS and Jrkt respectively contained cells
transduced with a non-silencing control vector or untreated Jurkat
cells. B) The levels of GMFG expression (grey bars) and chemotactic
responses (black bars) of each cell line were compared. Values are
presented as a percentage of the wild type expression and
migration levels (N = 3, +/− SEM).
Figure 1 GMFG is enriched in lymphocyte pseudopodia. Panel
A) The proteins in isolated pseudopodia (PS) or whole cell lysates
(WC) of Jurkat T cells separated by SDS-PAGE. The levels and protein
patterns were determined by staining for total protein (left panels)
and the levels of GMFG in each fraction were assessed by western
blot (right panels). Panel B) Quantitation of the intensity of the
GMFG bands observed in the western blots in A. The GMFG levels
were 45% greater in the pseudopodia than in the whole cell lysate
(n = 3, * p= 0.017). Panels C-F) Confocal images of GMFG
distribution in IL-2 dependent T cells. C, E) Arrowheads indicate the
presence of GMFG at the leading edge of the cell. D, F) Difference
interference contrast images of the same cells for comparison of cell
morphology.
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Additional file 5 and Additional file 6). This process was
repeated continuously, with little or no net movement
observed for the knockdown cells. Quantitation of track-
ing data comparing knockdown cells to controls indicated
a 58% decrease in median velocity, a 57% decrease in
median accumulated distance and a 74% decrease in the
median Euclidean distance traveled (Figure 3B). Thus, the
apparent accumulated distance traveled by these cells, was
actually a measure of repeated extension and retraction of
cellular processes from a fixed point. In reality there was
no net movement. These observations raised the possi-
bility that GMFG played a role in the regulation of
cellular adherence.
The effects of GMFG loss on T cell adhesion and integrin
expression
The relative levels of adhesion of GMFG-KD cells to
fibronectin was 1.5 to 2.0 fold that of nonsilencing
Figure 3 The effects of GMFG knockdown on T cell movement. Panel A) Control IL-2 dependent T cells containing a non-silencing construct
displayed random movement on a fibronectin coated surface (upper panel) which was not enhanced by the addition of SDF1 (middle panel).
GMFG knockdown resulted in the abrogation of most of the detectable movement, even in the presence of SDF1 (lower panel). Panel B).
Significant reductions were observed for the velocity (upper panel), accumulated distance (middle panel) and Euclidean distance (lower panel) of
GMFG knockdown cells relative to control cells. The difference between non-silencing and GMFG knockdown groups was statistically significant
(p< 0.001) in all three parameters.
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observed in Jurkat cells, CCRF-CEM cells and IL-2
dependent peripheral blood T-lymphocytes using two
different GMFG shRNA constructs for each cell line.
Members of the β1 integrin family are the predominant
mediators of lymphocyte cell adhesion to extracellular
components such as fibronectin [11]. The surface expres-
sion of β1 integrin on GMFG-KD cells was increased by61% compared with control cells (Figure 5A). Both α4β1
and α5β1 integrins have been shown to contribute to
lymphocyte fibronectin binding. There was a 66% increase
in α5 integrin levels in GMFG-KD cells. In contrast, the
levels of the α4 subunit were unaffected in the GMFG-KD
cells. These results indicated that the loss of GMFG was
associated with altered β1and α5 expression levels and
patterns.
Figure 4 The effects of GMFG knockdown on T cell adherence.
The impact of GMFG knockdown on Jurkat, CCRF-CEM, and IL-2
dependent T cell adherence to immobilized fibronectin was
compared relative to that of their corresponding control cells. Two
different GMFG targeting shRNAs were used to generate distinct cell
lines (GMFG KD1 and GMFG KD2). Adhesion is expressed as a
percentage of the adherence of the corresponding non-silencing
control cells (N = 3, +/− SEM; * p< 0.05; ** p< 0.005).
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were examined using adhesion blocking antibodies spe-
cific for the β1 (3S3) and α5 (JBS5) subunits. Treatment
with 3S3 (reduced the adhesion of all three cell lines
to less than 10% of the input cells suggesting that β1
integrins are responsible for the bulk of the adhesion
of these cells to fibronectin (Figure 5B). In contrast
JBS5 appeared to only inhibit the increased level of ad-
hesion found in the GMFG-KD cells implying that the
elevated adhesion of these cells to fibronectin was
mediated by α5β1.
The α5β1 integrin binds specifically to an RGD motif
within fibronectin [12,13] and this interaction can be
inhibited with synthetic peptides containing the RGD
sequence. The addition of RGD peptide to cell suspen-
sions of a CCRF-CEM GMFG-KD line reduced the fibro-
nectin adhesion of these cells to levels comparable to
those of control non-silencing cells (Figure 5C). Similar
results were obtained for a Jurkat GMFG-KD line (not
shown). Interestingly, RGD had no discernible effect on
the binding of control cells to fibronectin. These data
further support the conclusion that the increased adhe-
sion of GMFG-KD cells is due to an increase in the
levels of functional α5β1 integrin on the surface of these
cells.
Integrins have multiple conformations corresponding
to different affinities [14,15]. Changes to the activation
state of α5β1 integrins could contribute to the observed
increase in adhesion of the GMFG-KD lines. The HUTS-4
antibody is specific for the active conformation of β1
integrins [16]. Flow cytometry analysis of GMFG-KD
lines and controls using this antibody demonstrated anincrease in the amount of active β1 integrin on the
surface of GMFG-KD cells (Figure 5D). These data
demonstrated that increased α5β1 integrin was accom-
panied by an increase in the activation state of the β1
subunit suggesting that changes in the levels and activities
of α5β1 are responsible for the increased adhesion of
GMFG-KD cells to fibronectin.
GMFG loss is associated with altered β1 integrin
distribution
The distribution of β1 integrins on non-silencing and
GMFG-KD cells was examined by confocal immuno-
fluorescent microscopy. Fluorescence intensity plots
were constructed along lines drawn through the central
polarized axis of T-cells (Figure 6A). The distributions of
the β1 integrins along these axes were then categorized
as either tail biased, unbiased or front biased. Sixty cells
from each cell line were processed in this fashion as a
sampling of the overall distribution of β1 integrins. Line
plots from three representative cells from each category
were overlaid to produce the graphs shown in Figure 6A,
along with a single cell image to illustrate the staining
patterns. GMFG-KD cells predominantly displayed a tail
bias (80% for each knockdown line) while only 22% of
control cells fell into this category (Figure 6B). The
knockdown cells were rarely observed to have a front
bias (~5%), while the control cells were evenly split
between front biased and unbiased (~40% each).
GMFG loss leads to increased β2 integrin expression and
adhesion to ICAM-1
Analysis of LFA-1 (αLβ2 integrin) surface expression on
GMFG-KD cells revealed a modest but consistent
increase (Figure 7A). The increase ranged from 58 to
61% above that of controls in both the knockdown lines
examined. Similar results were seen with both CCRF-
CEM and Jurkat cells (not shown). This increased
surface expression of LFA-1 correlated with an
enhanced adherence of these cells to ICAM-1 relative to
non-silencing control cells (Figure 7B). The two knock-
down lines tested showed statistically significant
increases (p< 0.05) in adhesion by 43% and 85% (mean
of three experiments).
Discussion
The present study demonstrated that GMFG is enriched
in the pseudopodia of migrating human T lymphocytes.
Interference with GMFG expression markedly inhibited
SDF1 stimulated chemotaxis. This effect was associated
with reduced migration and a failure to sustain cellular
polarity and directed movement. The inability of the
cells to move was associated with an increase in total β1
integrin levels which included elevated expression levels
of the high-affinity conformation of the β1 subunit.
Figure 5 (A) The effects of GMFG knockdown on CCRF-CEM T cell integrin expression levels and functional activities. A) The levels of β1,
α4 and α5 integrin expression were determined by flow cytometry for a non-silencing control and GMFG knockdown cells (representative
example of 3 experiments). B) The effects of a control (HSA), or adhesion blocking antibodies to integrin on the adhesion of control and GMFG
knockdown cells to fibronectin. C) The effects of an RGD containing peptide on the adhesion of non-silencing and GMFG knockdown cells to
fibronectin. In the absence of peptide, the number of adherent GMFG knockdown cells was 91% higher than control cells (p< 0.001). The RGD
peptide did not have any significant effect on the adherence of non-silencing control cells. Data is shown for cell lines created from CCRF-CEM T
cells and is representative of two separate experiments. D) The effects of GMFG knockdown on the expression levels of the high-affinity binding
conformation of β1 integrin. The control and GMFG-KD cells were stained with HUTS-1. HUTS-1 staining was greater in knockdown cells (grey
and dotted lines) than in comparable non-silencing control cells (black line). Data is representative of two separate experiments.
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cells to fibronectin appeared to be predominantly related
to increased α5β1 levels. This was further supported by
the fact that a synthetic RGD containing peptide and
inhibitory antibodies specific for the α5 and β1 subunits
reduced the elevated adhesion of the GMFG-KD lines to
levels comparable with control cells. The loss of GMFG
also seems to impact on the distribution of integrin
molecules, as there is a propensity for GMFG-KD cells
to accumulate β1 integrins within the uropod. This accu-
mulation, in combination with increased surface expres-
sion levels, was consistent with failure of the cells to
detach from the substrate. Furthermore the changes inintegrin levels and activity were not restricted to the α5β1
integrin suggesting that GMFG activity plays a broader
role in control of cellular adhesion.
GMFG is a member of the actin-depolymerizing factor
homology (ADF-H) family with actin depolymerizing
activity [7]. Recent studies indicate that GMFG mediated
depolymerization differs from that of other ADF-H
members such as cofilin [10]. GMFG does not bind
directly to actin, rather it interacts with Arp2/3 complex
members which can induce debranching of actin fila-
ments. Interestingly, while GMFG reduces the rate of
actin filament assembly, the distribution and absolute
amount of F-actin ultimately produced during in vitro
Figure 6 The effects of GMFG knockdown on β1 integrin distribution in CCRF-CEM cells. Control and GMFG-KD cells were plated on
fibronectin coated surfaces, fixed and stained for β1 integrin expression. The intensity of staining fluorescence was measured along the length of
the cell. Cells were categorized as having a tail bias, no bias or front bias with respect to integrin distribution. The tail and front of each cell is
indicated respectively by ‘T’ and ‘F’. A) Line plots for three representative cells and an image of a cell in each category. B) The proportions of cells
in each category. Results are from the analysis of 60 cells from each cell line.
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shown). These observations raise the possibility that
GMFG may be required for the transition from branchedFigure 7 The effects of GMFG knockdown on LFA-1 expression and fu
black lines) show an increase in the relative surface expression of LFA-1 wh
knockdown cells to ICAM-1 was increased in comparison to a control non-
(p< 0.05) for each of the knockdown lines when compared to the control.
standard error.actin networks at the leading edge to more filamentous
structures that are at immediately proximal to the lead-
ing edge of migrating cells. These filaments may providenction of CCRF-CEM cells. A) GMFG knockdown cells (dotted and
en compared to control cells (grey line). B) The adhesion of GMFG
silencing line. The difference observed was statistically significant
The results shown represent the mean of three experiments +/− the
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rins through integrin associated actin binding proteins.
Such interactions could also regulate integrin activation
and distribution to generate the adhesion required for
cell movement.
Several GMFG interaction partners have been identi-
fied to date. GMFG was identified in immunoprecipi-
tates of Arp2/3 complexes in Hela cells that were
overexpressing GMFG [7]. Subsequently, several groups
confirmed the interaction of murine, yeast or dictyoste-
lium GMFs and the Arp2/3 complex using purified pro-
teins [9,10]. WAVE2 was also co-precipitated with Myc
tagged GMFG in dHL60 [5]. However it is unclear if the
latter interaction relates to cell motility rather than
chemotaxis as these results were obtained with cells that
had not been treated with exogenous chemokine.
The present studies demonstrated a role for GMFG in
the control of T cell adhesion and its subsequent effects
on cell migration in stably transduced lymphocyte lines
and short term IL2 dependent peripheral blood T cells.
The loss of GMFG has also been shown to decrease the
chemotactic responses of both PMN and differentiated
HL60 cells [5]. The phosphorylation levels of p21 acti-
vated kinases (PAK 1 or PAK 2) and p38 MAPK were
also found to be decreased following fMLF or CXCL8
stimulation of dHL60 cells. PAK1/2 plays multiple roles
in the regional regulation of actin dynamics and myosin
function [17]. The strength of focal adhesions can be
regulated by Pak1/2 activity as inhibition of either the
activity or expression of Pak1/2 results in increased
numbers of nascent long lived adhesions. The net effect
of these alterations is a reduction in cellular migration.
Additionally, the conformation of α5β1 integrin is
known to switch from low to high affinity in focal adhe-
sions [18]. Hence the increased proportion of activated
β1 integrin observed on GMFG-KD cells would be con-
sistent with a Pak1/2 mediated increase in the number
of focal adhesions. An intriguing possibility is that
GMFG alters cytoskeletal organization which impacts on
the frequency and properties of integrin contacts with
the extracellular matrix. The strength of α5β1 binding
can be enhanced by cytoskeletal tension forces generated
by myosin II [19], and it is conceivable that GMFG
could be involved in the regulation of force generation
by its effects on the cytoskeleton. The observed changes
in the integrin expression patterns and activity may be a
reflection of architectural changes that accompany the
shifts in motility induced by GMFG loss. These are
points for future examination which could provide new
insights as to the regulation of lymphocyte adhesion.
Conclusions
GMFG is required for lymphocyte migration. The loss of
GMFG results in the selective increase of integrinexpression, leading to altered uropod retraction and
reduced persistence of leading edge protrusions. These
changes could be a result of either the direct actions of
GMFG on integrin properties or an indirect conse-
quence of possible alterations in cytoskeletal dynamics
associated with GMFG loss. It is unclear if the effects of
GMFG loss on chemotaxis derive from the inability of
cells lacking this protein to respond to chemotactic
stimuli or their failure to sustain the directionality
required for chemotaxis. Collectively this data suggests




Unless otherwise noted, all reagents and materials were
obtained from Invitrogen. Transwell inserts were
obtained from Corning Inc. Life Sciences (Lowell, MA,
USA). The GMFG antibody (13625-1-AP) was obtained
from Proteintech (Chicago, IL, USA), the ACTR2 anti-
body (ab49674) was obtained from Abcam (Cambridge,
MA, USA) and the ARPC2 (07–227) and HUTS-4
(MAB2079Z) antibodies were obtained from Millipore.
Integrin subunit antibodies were prepared in-house. The
antibody to CXCR4 (MAB170), recombinant SDF1 and
recombinant IL-2 were purchased from R&D Systems
(Minneapolis, MN, USA). Integrin antibodies to α5
(JBS5), β1 (JB1A and 3S3), and LFA-1 were prepared
in-house. The protease inhibitor cocktail (P8340) was
obtained from Sigma. Fibronectin was obtained from
Chemicon.
Cell lines and tissue culture
All cell lines were maintained at 37°C in a humidified
5% CO2 atmosphere. The human lymphoid cell lines,
Jurkat and CCRF-CEM, were cultured in RPMI 1640
medium supplemented with 10% FBS. Cells transfected
with shRNAmir constructs were maintained under
standard conditions with the addition of 1 μg/mL puro-
mycin to the medium for selection.
Peripheral blood mononuclear cells (PBMC) were iso-
lated from the whole blood of healthy donors by Ficoll
gradient centrifugation. The cells were washed twice
with PBS, resuspended in AIM V CTS Serum Free
Medium (Invitrogen) and stimulated for 16 hours with
phytohaemagglutinin P (5 μg/mL). The nonadherent
lymphocytes were harvested by centrifugation (500 × g
for 5 minutes) and resuspended in fresh medium supple-
mented with IL-2 12.5 ng/mL. All cell lines were subcul-
tured in fresh IL-2 containing media every 2–3 days. All
samples were obtained with informed consent using a
protocol approved by the University of Manitoba,
Research Ethics Board.
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Migration assays were performed as a modification of a
previously described method [20], and the same protocol
was employed for all cell lines. Prior to performing
migration assays cells were split to a density of 2 × 105
cells/mL and cultured overnight. Cells were collected by
centrifugation (400 × g for 5 minutes), washed twice with
serum free RPMI containing 0.1% BSA and resuspended
in this medium prior to performing the assay.
Migration assays were performed in triplicate in 96
well plates containing inserts with 5 μm diameter pores
according to the manufacturer’s instructions (Corning
Life Sciences, Lowell, MA, USA). Briefly, 3 × 105 cells
were added to the upper chamber of each transwell and
SDF-1 (50 ng/mL in RPMI+ 0.1% BSA) was dispensed
into the lower chamber of the transwells as chemo-
attractant. Cells were allowed to migrate for 2.5 hours at
37°C. Upon completion of the assay, cells were recov-
ered from both the reservoirs and transwells and trans-
ferred to separate standard 96 well plates. Cell numbers
were determined by the addition of 10 μL of Celltiter 96
Aqueous One cell proliferation assay reagent (Promega
Corp.) to each well followed by incubation at 37°C for 3
hours. Percent migration was calculated from the ratio of
cells in the reservoir to the initial input (sum of reservoir
plus transwell), and multiplying by 100. Spontaneous mi-
gration was consistently measured to be less than 5% of
the total cell number and was discounted for the purposes
of this calculation.
Pseudopodia isolation and analysis
Jurkat cells (7 × 106/24 mm 3.0 μm diameter pores trans-
well insert) were stimulated with SDF1 (50 ng/mL) for
90 minutes and the pseudopodia on the underside of the
insert were solubilized briefly (~1 second) in a 200 μL
droplet of solubilisation buffer (10 mM ammonium
bicarbonate, pH 7.4/1.0% SDS/2 mM sodium vanadate/
protease inhibitor cocktail). Control whole cell samples
were prepared by lysing 5 × 106 Jurkat cells in the same
solubilisation buffer. Three biological replicates were
prepared for both the pseudopodia and control samples.
Samples were stored at −20°C until analysis.
LC-MS/MS was performed as previously described
(Dwivedi et al., 2008) using a nanoflow Tempo LC system
(Eksigent, Dublin, CA) coupled to a Qstar Elite mass spec-
trometer (Applied Biosystems, Foster City, CA). Each di-
gest was resuspended in 50 μL of 2% acetonitrile/1%
formic acid in water (v/v). A 20 μL volume of each digest
was analysed and each fraction was injected twice to pro-
vide technical replication of the LC-MS/MS analysis.
Mass spectrometry data analysis
The raw MS data files were converted to the Mascot
generic file format using the Mascot.dll script includedwith Analyst QS. The files corresponding to the fractions
of individual samples were concatenated and submitted
for protein identification using the X!Tandem search
engine that is a part of the Global Proteome Machine.
Standard settings were used for the analysis of QTOF
data. Searches were performed against the human
sequence database. Carbamidomethylation of cysteine
was selected as a consistent modification, while oxida-
tion of methionine and tryptophan as well as deamida-
tion of asparagine and glutamine were selected as
potential modifications. The measurement error window
was set to 100 ppm and trypsin was selected as the pro-
tein cleavage specification.
Virus packaging of shRNAmir constructs
Virus packaging was accomplished according to the meth-
ods provided by the manufacturer (Thermo Scientific Open
Biosystems Expression Arrest – The RNAi Consortium
(TRC) Lentiviral shRNA, Technical Manual, Open Biosys-
tems, Thermo Scientific Inc.).
Transduction of T cells and western blot assessment of
knockdown
Cells (3 × 105) in 0.5 mL of RPMI 1640 with 10% FCS
were mixed with 0.5 mL virus containing supernatant at
an MOI of 1 and incubated at 37°C for 2 hours. The
cells were spun at 200 × g for 10 minutes and resus-
pended in 1 mL of RPMI 1640 with 10% FCS for culture.
Transduced cells were positively selected by addition of
puromycin (1 μg/mL) to the media after 72 hours of cul-
ture. The efficiency of silencing of target protein expres-
sion was assessed by western blot. Aliquots of
transduced cells were collected and lysed on ice for 2
hours in lysis buffer containing 50 mM Tris (pH 7.5), 1%
SDS, protease inhibitor cocktail (Sigma-Aldrich, St.
Louis, MO, USA), and 0.1% benzonase nuclease (v/v of
E1014-25KU, Sigma-Aldrich, St. Louis, MO, USA). The
samples were centrifuged at 10,000 rpm for 5 min and
20 μg total protein from each sample was separated on a
4–10% SDS-PAGE. The proteins were transferred to
nitrocellulose membrane and blotted with appropriate
primary antibody and HRP-conjugated secondary anti-
body. Blots were developed by enhanced chemilumines-
cence (ECL). A blot of GAPDH was used to obtain a
measure of sample loading and the GAPDH signal was
used to normalize target specific bands among samples.
For PBMC, knockdown was estimated using immuno-
fluorescence microscopy and is described below.
Immunofluorescence microscopy
96-well glass bottom plates were coated with fibronectin
by incubating for 1 hour at room temperature or over-
night at 4°C with a solution of 10 μg/mL fibronectin in ster-
ile saline. Wells were rinsed three times for 5 minutes with
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lymphocytes were diluted to a density of 5 × 105 cells/mL
in Hank’s Buffered Salt Solution (HBSS) + 0.1% BSA and
100 μL of cell suspension was dispensed into individual
wells. SDF1 was added to a final concentration of 50 ng/
mL to induce random migration and polarization. Cells
were incubated for 20 minutes at 37°C, after which the cells
were fixed by the addition of 50 μL of 4% paraformaldehyde
(v/v) in saline for 10 minutes at 37°C. Care was taken to
maintain the temperature of the plate before and during
this step. After carefully aspirating the fixing solution from
each well, fixation was quenched by the application of 100
μL of 10 mM ethanolamine in PBS for 5 minutes at room
temperature. Cells were permeabilized by treatment with
0.1% (v/v) Triton X-100 for 10 minutes at room
temperature followed by a single wash with saline.
Primary antibodies were applied at 1 μg/mL in saline
and incubated for one hour at 37°C. Cells were washed
three times with saline prior to the application of second-
ary antibodies (Goat anti-Rabbit IgG-Cy2, GoatαMouse
IgG-AlexaFluor488, or Goat anti-Rabbit-AlexaFluor594)
at a dilution of 1:200 in saline. Cells were incubated with
the secondary antibodies for 30 minutes at 37°C followed
by a single wash with saline. 100 μL of 3% n-propylgallate
in 90% glycerol was added to each well as an antifade re-
agent. Cells were imaged immediately following stain-
ing on a Zeiss Observer. Z1 microscope using a
Zeiss Plan-Apochromat 63x/1.4 or 40x/0.95 objective.
Confocal imaging was performed on a Zeiss LSM 710 Ob-
server station using the same objective. Image acquisition
and processing was performed using the AxioVision v4.8.0
software used to operate the microscope.
Flow cytometry
Cells (1 × 106 cells/sample) were prepared for flow cyto-
metry analysis by fixation in 1% paraformaldehyde for
10 minutes, followed by a 10 min quench in 10 mM
ethanolamine. Fixed cells were incubated with the
appropriate primary antibody prepared as a 1:200 dilu-
tion in PBS for 1 hour at room temperature. Cells were
then washed twice with PBS and incubated for 30 min
with an AlexaFluor 488 conjugated goat anti-mouse
secondary antibody. Samples and appropriate staining
controls were analysed using a custom built FACSArray
(BD Biosciences) fitted with a 96-well plate sample de-
livery system and blue sample excitation laser. Data ana-
lysis and figures were prepared using FlowJo software
(version 7.5.5).
Adhesion assays
96 well plates were coated with fibronectin (10 μg/mL in
PBS) or ICAM-1 (5 μg/mL in PBS) for one hour at room
temperature. Cells were initially labeled with the fluores-
cent reagent Calcein-AM (Invitrogen) according to themanufacturer’s instructions. Washed cells were plated at
2.5 × 104 per well in 100 μL of media and incubated at
37 C for 30 min. Adhesion was assessed by comparing
the levels of adherent cells following aspiration as a
percentage of the total cellular input. The number of
cells retained was estimated based on fluorescence readings
taken from each well at the end of the assay. The results
were then expressed as the percent adhesion for non-
silencing control cells (which was taken as 100% of
‘normal’ adhesion) to enable simplified comparison of
replicate experiments and different cell types. In assays
employing the RGD peptide as an inhibitor of integrin
binding, RGD peptide was added at a concentration of
250 μg/mL to the cells prior to plating them on fibronectin.
Statistical analysis
For migration and adhesion assays, samples and controls
were measured in triplicate. The standard error of the
mean was calculated and used to indicate error ranges
all graphs. Probabilities of statistical significance were
calculated using a student’s t-test, and p-values were
reported on graphs and in figure legends. All calcula-
tions were performed in Sigmaplot (v11).Additional files
Additional file 1: Microsoft Excel table. List of peptides identified by
mass spectrometry from GMFG. This table includes a list of peptides from
the protein GMFG that were identified as part of a larger proteomics
screen of T cell pseudopodia.
Additional file 2: Windows media player video clip. GMFG-KD cell
movement video #1. This video clip shows an example of the movement
of a GMFG-KD primary T lymphocyte on a fibronectin coated surface.
Additional file 3: Windows media player video clip. GMFG-KD cell
movement video #2. This video clip shows an example of the movement
of a GMFG-KD primary T lymphocyte on a fibronectin coated surface.
Additional file 4: Windows media player video clip. GMFG-KD cell
movement video #3. This video clip shows an example of the movement
of a GMFG-KD primary T lymphocyte on a fibronectin coated surface.
Additional file 5: Windows media player video clip. GMFG-KD cell
movement video #4. This video clip shows an example of the movement
of a GMFG-KD primary T lymphocyte on a fibronectin coated surface.
Additional file 6: Windows media player video clip. Control cell
movement video. This video clip shows an example of the movement of
a control primary T lymphocyte on a fibronectin coated surface.Authors’ contributions
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